These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5935787)

  • 1. [The effect of ethyl-chlorphenoxy-isobutyrate on serum lipid values in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diezendy S; Erdélyi G
    Orv Hetil; 1966 May; 107(22):1020-2. PubMed ID: 5935787
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T
    Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979
    [No Abstract]   [Full Text] [Related]  

  • 4. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V; Schneiderman B; Finatti AA; Netto RF
    Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Med Welt; 1969 Aug; 31():1715-7. PubMed ID: 4895455
    [No Abstract]   [Full Text] [Related]  

  • 8. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G; Gibelli A; Giarola P
    Clin Ter; 1966 Jul; 38(1):27-38. PubMed ID: 4230052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of clofibrate on serum lipids in atherosclerosis].
    Gietz E
    Med Klin; 1967 Mar; 62(9):336-8 passim. PubMed ID: 5593571
    [No Abstract]   [Full Text] [Related]  

  • 13. Measures to reduce the serum lipid levels in coronary heart disease.
    Connor WE
    Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic influence on the blood lipids in manifest coronary sclerosis].
    Aschenbeck G
    Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of Atromid S on lipid metabolism in coronary insufficiency].
    Gabryś B; Konturek S; Keita-Fyda A
    Pol Tyg Lek; 1968 Oct; 23(42):1608-10. PubMed ID: 5702858
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 19. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M
    Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.